Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 28, 2024

SELL
$87.78 - $105.45 $13,167 - $15,817
-150 Reduced 74.26%
52 $5.38 Million
Q3 2023

Feb 28, 2024

BUY
$90.94 - $199.54 $9,184 - $20,153
101 Added 100.0%
202 $18.4 Million
Q1 2023

Feb 28, 2024

BUY
$132.34 - $159.14 $13,366 - $16,073
101 New
101 $16.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Acima Private Wealth, LLC Portfolio

Follow Acima Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acima Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acima Private Wealth, LLC with notifications on news.